HOME Top Market Reports Contrast Media/Contrast Agents Market by Product (Iodinated, Gadolinium, Barium, Microbubble), by Procedure (X-Ray/CT, MRI, Ultrasound), by Application (Radiology, Interventional Radiology, Interventional Cardiology) - Global Forecasts to 2020

Contrast Media/Contrast Agents Market by Product (Iodinated, Gadolinium, Barium, Microbubble), by Procedure (X-Ray/CT, MRI, Ultrasound), by Application (Radiology, Interventional Radiology, Interventional Cardiology) - Global Forecasts to 2020

By: marketsandmarkets.com
Publishing Date: July 2015
Report Code: MD 3577

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The contrast media/contrast agents market has been segmented on the basis of product, method, procedure, indication, route of administration, application, and region. The increase in demand for diagnostics and image-guided procedures, increase in approvals for various contrast agents, and increase in aging population and chronic diseases are among the major factors driving this market. In addition, the improving healthcare infrastructure in emerging markets and the increase in the number of public and private diagnostic centers further propel the growth of the contrast media market. Moreover, strong product pipelines of the market players, coupled with the increasing research studies regarding applications of various contrast agents, are expected to create opportunities for market growth in the near future.

However, various risks associated with the use of contrast agents, along with the need of skilled professionals for administering the same, may pose as a restraint for the growth of the global contrast agents market in the coming years. The development of other imaging solutions such as neutron and gamma imaging can also pose challenges for the contrast agents market in the near future.

Some of the major players in the global contrast media market include Bayer Healthcare (Germany), GE Healthcare (U.K.), Guerbet Group (France), Bracco Imaging S.p.A. (Italy), Mallinckrodt PLC (Ireland), and Lantheus Medical Imaging (U.S.), among others.

Scope of the Report:

This research report categorizes the global contrast media market into the following segments:

Contrast Media/Contrast Agents Market, by Product

  • Barium-Based Contrast Media
  • Iodinated Contrast Media
  • Gadolinium-Based Contrast Media
  • Microbubble Contrast Media

Contrast Media/Contrast Agents Market, by Procedure

  • X-ray/Computed Tomography (CT)
  • Magnetic Resonance Imaging (MRI)
  • Ultrasound

Contrast Media/Contrast Agents Market, by Route of Administration

  • Oral Contrast Media
  • Injectable Contrast Media
  • Rectal Contrast Media
  • Urethral Contrast Media

Contrast Media/Contrast Agents Market, by Indication

  • Cardiovascular Disorders
  • Oncology
  • Gastrointestinal Disorders
  • Musculoskeletal Disorders
  • Neurological Disorders
  • Nephrological Disorders

Contrast Media/Contrast Agents Market, by Application

  • Radiology
  • Interventional Radiology
  • Interventional Cardiology

Contrast Media/Contrast Agents, by Region

  • North America
  • U.S.
  • Canada
  • Europe
  • EU5
  • Rest of Europe (RoE)
  • Asia-Pacific
  • Rest of the World (RoW)

Table of Contents

1 Introduction (Page No. - 14)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 17)
           2.1.1 Research Methodology Steps
           2.1.2 Secondary and Primary Research Methodology
                    2.1.2.1 Secondary Research
           2.1.3 Key Data From Secondary Sources
                    2.1.3.1 Primary Research
                    2.1.3.2 Key Industry Insights
           2.1.4 Key Data From Primary Sources
           2.1.5 Key Insights From Primary Sources
           2.1.6 Market Size Estimation Methodology
           2.1.7 Market Forecast Methodology
           2.1.8 Market Data Validation and Triangulation
           2.1.9 Assumptions

3 Executive Summary (Page No. - 28)
    3.1 Introduction
    3.2 Current Scenario
    3.3 Future Outlook
    3.4 Conclusion

4 Premium Insights (Page No. - 33)
    4.1 Global Contrast Media/ Contrast Agents Market
    4.2 Contrast Media/ Contrast Agents Market, By Product  and Route of Administration
    4.3 Contrast Media/ Contrast Agents Market, By Indication (2015 vs. 2020)

5 Market Overview (Page No. - 37)
    5.1 Market Dynamics
    5.2 Market Segmentation
           5.2.1 Drivers
                    5.2.1.1 Increase in Demand for Diagnostics & Image Guided Procedures Influences the Sales of Contrast Media
                    5.2.1.2 Increasing Approvals for Contrast Agents
                    5.2.1.3 Increase in the Number of Public and Private Diagnostic Centers to Improve Diagnostic Imaging Services
                    5.2.1.4 Rising Number of Cancer Patients Responsible for Increasing the Number of Diagnostic Procedures
                    5.2.1.5 Increasing Prevalence of Diseases Associated With the Growth in the Aging Population is Driving the Demand of Various Diagnostic Imaging Modalities
                    5.2.1.6 Improving Healthcare Infrastructure in Emerging Markets
           5.2.2 Restraints
                    5.2.2.1 Risk Associated With Contrast Agents
                    5.2.2.2 Need for Highly Skilled Professionals
           5.2.3 Opportunities
                    5.2.3.1 Strong Product Pipeline Likely to Boost the Contrast Media Market
                    5.2.3.2 Increasing Research on Contrast Agent and Their Applications
           5.2.4 Challenge
                    5.2.4.1 Development of Gamma and Neutron Imaging Solutions

6 Global Contrast Media/ Contrast Agents Market, By Product (Page No. - 52)
    6.1 Introduction
    6.2 Barium- Based Contrast Media
    6.3 Iodinated Contrast Media
    6.4 Gadolinium Based Contrast Media
    6.5 Microbubbles

7 Global Contrast Media/ Contrast Agents Market, By Medical Procedure (Page No. - 62)
    7.1 Introduction
    7.2 X-Ray/CT
    7.3 MRI
    7.4 Ultrasound

8 Global Contrast Media/ Contrast Agents Market, By Route of Administration (Page No. - 70)
    8.1 Introduction
    8.2 Oral Contrast Media
    8.3 Injectable Contrast Media
    8.4 Rectal Contrast Media
    8.5 Urethral Contrast Media

9 Global Contrast Media/ Contrast Agents Market, By Indication (Page No. - 78)
    9.1 Introduction
    9.2 Cardiovascular Disorders
    9.3 Oncology
    9.4 Gastrointestinal Disorders
    9.5 Neurological Disorders
    9.6 Nephrological Disorders
    9.7 Musculoskeletal Disorders

10 Global Contrast Media/ Contrast Agents Market, By Application (Page No. - 87)
     10.1 Introduction
     10.2 Radiology
     10.3 Interventional Radiology
     10.4 Interventional Cardiology
     10.5 Introduction
     10.6 North America
             10.6.1 U.S.
                        10.6.1.1 Increase in the Number of Diagnostic Imaging Centers
                        10.6.1.2 Increase in the Ageing Population and Rising Prevalence of Chronic Diseases in the U.S.
                        10.6.1.3 Reimbursement Cuts Under Obama Care
             10.6.2 Canada
                        10.6.2.1 High Incidence Rate of Cancer, Cardiovascular Diseases and Diabetes  in Canada
                        10.6.2.2 Increasing MRI and CT Examinations and Government Funding to Boost the Canadian Market
     10.7 Europe
             10.7.1 EU5
                        10.7.1.1 Increase in Investment By Market Players
                        10.7.1.2 Increasing Incidence and Prevalence of Cancer
                        10.7.1.3 Healthcare Spending Rises But Remains Weak in EU5 Countries
                        10.7.1.4 Shortage of Medical Imaging Instruments/Scanners Likely to Hamper the U.K. Market
             10.7.2 RoE
                        10.7.2.1 Increase Focus of Market Players in RoE Countries
                        10.7.2.2 Increasing Number of MRI and CT Scanners
     10.8 Asia-Pacific
             10.8.1 Rise in the Ageing Population and Increasing Cancer Incidence
             10.8.2 Rising Number of Diagnostic Facilities/Procedures in Japan
             10.8.3 Expansion of International Players in China and India
             10.8.4 Increasing R&D Investments in China
             10.8.5 Favourable Regulatory Changes to Increase the Market in New  Zealand and  Australia
     10.9 Rest of the World
             10.9.1 Latin America
             10.9.2 The Middle East
             10.9.3 Africa

11 Competitive Landscape (Page No. - 136)
     11.1 Overview
     11.2 Market Share Analysis, Contrast Media/ Contrast Agents Market (2014)
             11.2.1 Bayer Healthcare
             11.2.2 GE Healthcare
     11.3 Competitive Situation and Trends
             11.3.1 Market Development (Product Approvals)
             11.3.2 Agreements/ Collaborations/ Partnerships/ Strategic Alliances/ Contracts/ Corporate Alliances
             11.3.3 Divestments /Investments
             11.3.4 Expansions
             11.3.5 Others

12 Company Profiles (Page No. - 150)
     12.1 GE Healthcare
             12.1.1 Business Overview
             12.1.2 Financials
             12.1.3 Product Portfolio
             12.1.4 Recent Developments
             12.1.5 MnM View
     12.2 Bayer Healthcare
             12.2.1 Business Overview
             12.2.2 Financials
             12.2.3 Product Portfolio
             12.2.4 Recent Developments
             12.2.5 MnM View
     12.3 Bracco Imaging S.P.A. (A Subsidiary of Bracco S.P.A.)
             12.3.1 Business Overview
             12.3.2 Financials
             12.3.3 Product Portfolio
             12.3.4 Recent Developments
             12.3.5 MnM View
     12.4 Guerbet Group
             12.4.1 Business Overview
             12.4.2 Financials
             12.4.3 Product Portfolio
             12.4.4 Recent Developments
             12.4.5 MnM View
     12.5 Mallinckrodt PLC
             12.5.1 Business Overview
             12.5.2 Financials
             12.5.3 Product Portfolio
             12.5.4 Recent Developments
     12.6 Lantheus Medical Imaging
             12.6.1 Business Overview
             12.6.2 Financials
             12.6.3 Product Portfolio
             12.6.4 Recent Developments
     12.7 Nanopet Pharma Gmbh
             12.7.1 Business Overview
             12.7.2 Financials
             12.7.3 Product Portfolio
             12.7.4 Recent Developments
     12.8 CMC Contrast AB
             12.8.1 Business Overview
             12.8.2 Financials
             12.8.3 Product Portfolio
             12.8.4 Recent Developments
     12.9 Targeson, Inc. Pharma Co., Ltd.
             12.9.1 Business Overview
             12.9.2 Financials
             12.9.3 Product Portfolio
             12.9.4 Recent Developments
     12.10 Daiichi Sankyo
             12.10.1 Business Overview
             12.10.2 Financials
             12.10.3 Product Portfolio
             12.10.4 Recent Developments
     12.11 Subhra Pharma Private Limited
             12.11.1 Business Overview
             12.11.2 Financials
             12.11.3 Product Portfolio
             12.11.4 Recent Developments

13 Appendix (Page No. - 178)
     13.1 Discussion Guide
     13.2 Company Developments (2012-2015)
             13.2.1 GE Healthcare
             13.2.2 Bayer Healthcare
             13.2.3 Bracco Imaging S.P.A.
     13.3 Guerbet LLC
     13.4 Introducing RT: Real-Time Market Intelligence
     13.5 Available Customizations
     13.6 Related Reports


List of Tables (72 Figure)

Table 1 Increasing Demand for Diagnostics and Image Guided Procedures Coupled With Rising Number of Approvals for Contrast Agents/Media are Driving the Contrast Media/ Contrast Agents Market
Table 2 Risk Associated With Contrast Agents is A Major Factor Restraining the Growth of the Contrast Media/ Contrast Agents Market
Table 3 Strong Product Pipeline and Increasing Research Activities Influence the Growth of the Contrast Media/ Contrast Agents Market
Table 4 Development of Gamma and Neutron Imaging Solutions Pose as A Challenge in the Growth of the Contrast Media/ Contrast Agents Market
Table 5 Contrast Media/ Contrast Agents Market Size, By Product, 20152020 ($Million)
Table 6 Contrast Media/ Contrast Agents Market Size for Barium-Based Contrast Media, By Region, 20152020 ($Million)
Table 7 Contrast Media/ Contrast Agents Market Size for Iodinated Contrast Media, By Region, 20152020 ($Million)
Table 8 Contrast Media/ Contrast Agents Market Size for Gadolinium Based Contrast Media, By Region, 20152020 ($Million)
Table 9 Contrast Media/ Contrast Agents Market Size for Microbubble Contrast Media, By Region, 20152020 ($Million)
Table 10 Contrast Media/ Contrast Agents Market Size, By Procedure, 20152020 ($Million)
Table 11 Contrast Media/ Contrast Agents Market Size for X-Ray/CT, By Region, 20152020            ($Million)
Table 12 Contrast Media/ Contrast Agents Market Size for MRI, By Region, 20152020 ($Million)
Table 13 Contrast Media/ Contrast Agents Market Size for Ultrasound, By Region, 20132020 ($Million)
Table 14 Contrast Media/ Contrast Agents Market Size, By Route of Administration, 20152020 ($Million)
Table 15 Contrast Media/ Contrast Agents Market Size for Oral Contrast Media, By Region, 2015-2020 ($Million)
Table 16 Contrast Media/ Contrast Agents Market Size for Injectable Contrast Media, By Region, 2015-2020 ($Million)
Table 17 Contrast Media/ Contrast Agents Market Size for Rectal Contrast Media, By Region, 2015-2020 ($Million)
Table 18 Contrast Media/ Contrast Agents Market Size for Urethral Contrast Media, By Region, 2015-2020 ($Million)
Table 19 Contrast Agents Market Size, By Indication, 2015-2020 ($Million)
Table 20 Contrast Agents Market Size for Cardiovascular Disorders, By Region, 2015-2020 ($Million)
Table 21 Market Size for Oncology , By Region, 2015-2020 ($Million)
Table 22 Market Size for Gastrointestinal Disorders, By Region, 2015-2020 ($Million)
Table 23 Market Size for Neurological Disorders, By Region, 2015-2020 ($Million)
Table 24 Market Size for Nephrological Disorders, By Region, 2015-2020 ($Million)
Table 25 Market Size for Musculoskeletal Disorders, By Region, 2015-2020 ($Million)
Table 26 Market Size, By Application, 20152020 ($Million)
Table 27 Market Size, By Applications, 20152020 ($Million)
Table 28 Market Size for Radiology, By Region, 2015-2020 ($Million)
Table 29 Market Size for Interventional Radiology, By Region, 2015-2020 ($Million)
Table 30 Market Size for Interventional Cardiology, By Region, 2015-2020 ($Million)
Table 31 Contrast Agents Market, By Region
Table 32 Contrast Agents Market Size, By Region, 20152020 ($Million)
Table 33 North America: Contrast Media/ Contrast Agents Market Size, By Procedure, 20152020 ($Million)
Table 34 North America: Market Size, By Product, 20152020($Million)
Table 35 North America: Market Size, By Route of Administration, 20152020 ($Million)
Table 36 North America: Market Size, By  Indication 20152020 ($Million)
Table 37 North America: Market Size , By Application 20152020 ($Million)
Table 38 U.S.: Contrast Media/ Contrast Agents Market Size, By Procedure, 20152020($Million)
Table 39 U.S: Market Size, By Product, 20152020($Million)
Table 40 U.S: Market Size, By Route of Administration, 20152020 ($Million)
Table 41 U.S: Market Size  By  Indication 20152020 ($Million)
Table 42 U.S: Market Size By  Application 20152020 ($Million)
Table 43 Canada: Contrast Media/ Contrast Agents Market Size, By Procedure, 20152020($Million)
Table 44 Canada: Market Size, By Product, 20132020($Million)
Table 45 Canada: Market Size, By Route of Administration, 20152020 ($Million)
Table 46 Canada: Market Size, By  Indication 20152020 ($Million)
Table 47 Canada: Market Size, By Application 20152020 ($Million)
Table 48 Europe: Contrast Media/ Contrast Agents Market Size, By Procedure, 20152020($Million)
Table 49 Europe: Market Size, By Product, 20152020($Million)
Table 50 Europe: Market Size, By Route of Administration, 20152020 ($Million)
Table 51 Europe: Market Size, By  Indication 20152020 ($Million)
Table 52 Europe: Market Size  By  Application 20152020 ($Million)
Table 53 EU5 : Contrast Media/ Contrast Agents Market Size, By Procedure, 20152020($Million)
Table 54 EU5: Market Size, By Product, 20152020($Million)
Table 55 EU5: Market Size, By Route of Administration, 20152020 ($Million)
Table 56 EU5: Market Size, By  Indication 20152020 ($Million)
Table 57 EU5: Market Size , By Application 20152020 ($Million)
Table 58 RoE: Contrast Media/ Contrast Agents Market Size, By Procedure, 20152020($Million)
Table 59 RoE: Market Size, By Product, 20152020($Million)
Table 60 RoE: Market Size, By Route of Administration, 20152020 ($Million)
Table 61 RoE: Market Size , By Indication 20152020 ($Million)
Table 62 RoE: Market Size , By Application 20152020 ($Million)
Table 63 APAC: Contrast Media/ Contrast Agents Market Size, By Procedure, 20152020($Million)
Table 64 APAC: Market Size, By Product, 20152020 ($Million)
Table 65 APAC: Market Size, By Route of Administration, 20152020 ($Million)
Table 66 APAC: Market Size, By Indication 20152020 ($Million)
Table 67 APAC: Market Size, By Application 20152020 ($Million)
Table 68 RoW: Contrast Media/ Contrast Agents Market Size, By Procedure, 20152020($Million)
Table 69 RoW: Market Size, By Product, 20152020($Million)
Table 70 RoW: Market Size, By Route of Administration, 20152020 ($Million)
Table 71 RoW: Market Size, By Indication 20152020 ($Million)
Table 72 RoW: Market Size, By  Application 20152020 ($Million)
 
 
List of Figures (38 Figures)
 
Figure 1 Research Methodology Steps
Figure 2 Sampling Frame: Primary Research
Figure 3 Break Down of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Market Size Estimation Methodology: Bottom-Up Approach
Figure 5 Market Size Estimation Methodology: Top-Down Approach
Figure 6 Market Forecast Methodology
Figure 7 Data Triangulation Methodology
Figure 8 Ultrasound Market  to Witness the Highest CAGR of 19.3% From 2015 to 2020
Figure 9 The Injectable Route of Administration Segment is Expected to Continue to Dominate the Contrast Media Market in the Forecast Period
Figure 10 Asia-Pacific is Slated to Witness the Highest Growth in the Contrast Media Market in the Forecast Period
Figure 11 Market Overview
Figure 12 Injectable Contrast Media- the Contrast Agents Market in 2015
Figure 13 Asia to Witness Highest Growth Rate During the Forecast Period
Figure 14 Cardiovascular Disorders Commanded the Largest Share
Figure 15 Contrast Media Medical Imaging Market Segmentation
Figure 16 Drivers, Restraints, Challenge, & Opportunities
Figure 17 Microbubble Contrast Media is the Fastest Growing Product Segment of the Contrast Media/ Contrast Agents Market
Figure 18 X-Ray/CT Accounts for the Largest Share of the Contrast Media/ Contrast Agents Market
Figure 19 Injectable Contrast Media is the Largest and Fastest Growing Segment in the Contrast Media/ Contrast Agents Market
Figure 20 X-Ray/CT Accounts for the Largest Share of the Market
Figure 21 Interventional Radiology is Largest and Fastest Growing Application Segment in Contrast Media/Contrast Reagents Market
Figure 22 North America Commanded the Largest Share of Contrast Media/ Contrast Agents Market
Figure 23 U.S. Commanded the Largest Share of North American Contrast Media/ Contrast Agents Market
Figure 24 EU5 Region Dominates the European Contrast Media/ Contrast Agents Market
Figure 25 Market Development ( Product Approvals) Was the Key Growth Strategy for Market Players
Figure 26 Global Contrast Media/ Contrast Agents Market Share, By Key Player, 2014
Figure 27 Battle for Market Share: Market Development (Product Approvals)
Figure 28 Was the Key Strategy (2012-2015)
Figure 29 Key Players Focusing on Market Development (Product Approvals), 20122015
Figure 30 Key Players Focusing on Agreements/ Collaborations/ Partnerships/ Strategic Alliances/ Contracts /Corporate Alliances, 20122015
Figure 31 Key Players Focusing on Divestments/ Investments, 20122015
Figure 32 Key Players Focusing on Expansions, 20122015
Figure 33 Key Players Focusing on Other Strategies, 20122015
Figure 34 GE Healthcare: Company Snapshot
Figure 35 Bayer Healthcare: Company Snapshot
Figure 36 Guerbet Group: Company Snapshot
Figure 37 Mallinckrodt PLC: Company Snapshot
Figure 38 Lantheus Medical Imaging: Company Snapshot

Contrast media/contrast agents are chemicals used in diagnostic imaging procedures. Contrast media signify a vital requirement of medical imaging as these agents provide better images of body structures and organs when visualized during medical procedures, such as X-ray, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and ultrasound procedures.

The global contrast agents market has been segmented on the basis of product, route of administration, indication, procedure, application, and region. In terms of product, the market is categorized into barium, iodinated, gadolinium, and microbubble contrast media. In 2015, the iodinated contrast media segment is estimated to account for the largest share of the contrast agents market, among the products. However, the microbubble contrast media market is expected to grow at the highest CAGR during the forecast period of 2015 to 2020.

On the basis of route of administration, the global market has been segmented into oral, injectable, rectal, and urethral routes. In 2015, the injectable segment is expected to account for the largest share of the market, among the different routes of administration.

The contrast media market, by indication, has been segmented into cardiovascular disorders, oncology, gastrointestinal disorders, musculoskeletal disorders, neurological disorders, and nephrological disorders. In 2015, the cardiovascular disorders segment is estimated to dominate the market, among indications.

Based on application, the market has been segmented into radiology, interventional radiology, and interventional cardiology. In 2015, the radiology segment is estimated to account for the largest share of the market, among the applications.

North America, Europe, Asia-Pacific, and Rest of the World (RoW) are the key regions considered for the geographic analysis of the global market. In 2015, North America is projected to dominate the global market, followed by Europe and Asia-Pacific. However, the Asia-Pacific market is expected to grow at the highest CAGR during the given forecast period, and also serve as a revenue pocket for companies offering contrast media/contrast agents.

The key factors that are expected to drive the growth of this market include the increase in demand for diagnostics and image-guided procedures; increase in approvals for various contrast agents; and increase in aging population and the incidence of chronic diseases. In addition, the improving healthcare infrastructure in emerging markets and the increase in the number of public and private diagnostic centers are further propelling the growth of the global contrast media/contrast agents market. Moreover, the strong product pipelines of the major market players, along with the increasing research studies regarding applications of various contrast agents, are expected to provide opportunities for further market growth in the near future.

However, the various risks associated with the use of contrast agents, along with the need of skilled professionals for administering the same, may pose as restraints for the growth of the concerned market. Furthermore, the development of other imaging solutions such as neutron and gamma imaging may pose as challenges for the growth of the market in the coming years.

Global Contrast Media/Contrast Agents Market Size, by Region, 2015 - 2020

Contrast Media Market

Source: American College of Radiology (ACR), World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), International Society of Radiology (ISR), Radiology Society of North America (RSNA), Journal of Radiology, National Institute of Health (NIH), International Life Sciences Institute (ILSI), National Kidney Foundation, The Organisation for Economic Co-operation and Development (OECD), Expert Interviews, and MarketsandMarkets Analysis

Note: The size of the bubble chart depicts the market size ($million) in 2015.

The global contrast media market for the forecast period of 2015 to 2020. This market is expected to reach a value of $5.17 Billion by 2020, from $4.21 Billion in 2015, at a CAGR of 4.2% during the period under consideration. The market is expected to be dominated by North America in 2015, followed by Europe, Asia-Pacific, and RoW. The Asia-Pacific market is expected to grow at the highest CAGR during the given forecast period.

Some of the major players in the global market include Bayer Healthcare (Germany), GE Healthcare (U.K.), Guerbet Group (France), Bracco Imaging S.p.A. (Italy), Mallinckrodt PLC (Ireland), and Lantheus Medical Imaging (U.S.), among others.

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports